Christian Rosas-Salazar

November 13, 2024

Study to explore antibiotics’ role in childhood asthma

Goal is to inform the design of microbiome-based therapeutics that can help deliver antibiotics safely during early life and reduce the burden of childhood asthma.

By Jessica Pasley
Registered respiratory therapist Natasha Vanderbilt, RRT, encourages 10-year-old Kate to exhale a complete breath during a lung function test in the Pediatric Pulmonary Medicine clinic. (photo by Susan Urmy)
June 14, 2024

Removing race improves accuracy of lung function testing in children

The study suggests the adjustment for race in spirometry resulted in an underreporting — and thus possibly undertreatment — of chronic lung diseases, including asthma and cystic fibrosis, in Black children.

By Bill Snyder
June 6, 2024

Stokes, Austin, Rosas-Salazar honored by the American Thoracic Society

The mission of the ATS is to promote the respiratory health of children and adolescents and to improve the care of children with respiratory disease through research, education, patient care and advocacy.

By Christina Echegaray
A clinical trial supports approval of a new medication to treat moderate-to-severe asthma in children.
April 24, 2023

Study finds early RSV infection linked to significantly increased risk of asthma in children

A Vanderbilt study has found that RSV infection in the first year of life is associated with a significantly increased risk of asthma in children.

By Nancy Humphrey
November 10, 2022

Study to explore nasal bacteria of children born by C-section

Vanderbilt is recruiting pregnant women scheduled to undergo a repeat cesarean section at VUMC for a study of potential interventions to change the bacteria living in the nose of children born by C-section.

By Nancy Humphrey
Contributors to the COVID-19 microbiome study include (front row, from left) Julie Bastarache, MD, Meghan Shilts, MS, MHS, (middle row, from left) Jodell Jackson, PhD, Suman Das, PhD, Angela Jones, MS, (back row, from left) Jonathan Schmitz, PhD, MD, Simon Mallal, MBBS, and Jordan Best, PhD.
March 11, 2021

‘Friendly’ bacteria may impact COVID severity

The U.S. Centers for Disease Control and Prevention (CDC) has awarded Vanderbilt University Medical Center a two-year, $3.7-million contract to determine genetic and bacterial factors that may increase the risk for severe illness and death from COVID-19.

By Bill Snyder
July 2, 2020

Fe y Salud webinar addresses disproportionate effects of COVID-19 on Latino community

The Latino community is affected disproportionately by COVID-19. News outlets report leaders and lawmakers calling its impact “catastrophic.” In the state of Tennessee, one-third of residents who test positive for the coronavirus are Hispanic, even though only 5.6 percent of the population is Hispanic.
By Matt Schorr
March 1, 2018

Study sheds light on how childhood RSV can lead to asthma

Infants who have higher amounts of the bacterium Lactobacillus present in their nose or upper part of the throat during an acute respiratory syncytial virus (RSV) infection are less likely to develop childhood wheezing later in life, a new Vanderbilt-led Center for Asthma Research study found.
By Christina Echegaray